Pfizer's Lung Cancer Drug Targets ALK Gene

May 17, 2012, 02:00 AM by Michael Croft

Wall Street Journal | Pfizer's new lung cancer drug is showing effectiveness against childhood cancers with defects in the ALK gene.

May 17, 2012 | Pfizer's new lung cancer drug is showing effectiveness against childhood cancers with defects in the ALK gene. The drug eradicated the cancer in seven of eight children with a form of lymphoma and two others with neuroblastoma. Wall Street Journal [subscription required]